Skip to menu Skip to content Skip to footer
Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 
Phone: 
+61 7 3176 7792

Overview

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Works

Search Professor Gerald Holtmann’s works on UQ eSpace

531 works between 1986 and 2025

41 - 60 of 531 works

2024

Conference Publication

Impact Of Economic And Psychosocial Factors On Symptom Severity In Patients With Disorders Of Gut-brain Interaction During The COVID-19 Pandemic: A Systematic Review And Meta-analysis

Kulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Wong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna, Mulak, Agata, Lee, Yeong Yeh and Holtmann, Gerald J. (2024). Impact Of Economic And Psychosocial Factors On Symptom Severity In Patients With Disorders Of Gut-brain Interaction During The COVID-19 Pandemic: A Systematic Review And Meta-analysis. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)03354-7

Impact Of Economic And Psychosocial Factors On Symptom Severity In Patients With Disorders Of Gut-brain Interaction During The COVID-19 Pandemic: A Systematic Review And Meta-analysis

2024

Journal Article

A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis

Jones, Michael P., Koloski, Natasha A., Walker, Marjorie M., Holtmann, Gerald J., Shah, Ayesha, Eslick, Guy D. and Talley, Nicholas J. (2024). A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis. American Journal of Gastroenterology, 119 (9), 1894-1900. doi: 10.14309/ajg.0000000000002751

A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis

2024

Journal Article

What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework

Koloski, Natasha, Duncanson, Kerith, Ramanathan, Shanthi Ann, Rao, Melanie, Holtmann, Gerald and Talley, Nicholas J (2024). What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework. BMJ Open, 14 (3) e076839, 1-8. doi: 10.1136/bmjopen-2023-076839

What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework

2024

Journal Article

Healthcare utilization patterns: irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux disease

Koloski, Natasha, Shah, Ayesha, Kaan, Iain, Ben Jacob, Ronen, Talley, Nicholas J., Jones, Michael P. and Holtmann, Gerald (2024). Healthcare utilization patterns: irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux disease. Digestive Diseases and Sciences, 69 (5), 1626-1635. doi: 10.1007/s10620-024-08297-w

Healthcare utilization patterns: irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux disease

2024

Journal Article

Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition

Williams, Thomas J., Moy, Naomi, Kaazan, Patricia, Callaghan, Gavin, Holtmann, Gerald and Martin, Neal (2024). Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition. Journal of Parenteral and Enteral Nutrition, 48 (2), 165-173. doi: 10.1002/jpen.2589

Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition

2024

Journal Article

Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis

Andresen, Viola, Shah, Ayesha, Fink, Careen, Rabini, Sabine, Wargenau, Manfred and Holtmann, Gerald (2024). Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis. Digestion, 105 (3), 166-174. doi: 10.1159/000535672

Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis

2024

Journal Article

Erratum: autism-related dietary preferences mediate autism-gut microbiome associations

Yap, Chloe X., Henders, Anjali K., Alvares, Gail A., Wood, David L.A., Krause, Lutz, Tyson, Gene W., Restuadi, Restuadi, Wallace, Leanne, McLaren, Tiana, Hansell, Narelle K., Cleary, Dominique, Grove, Rachel, Hafekost, Claire, Harun, Alexis, Holdsworth, Helen, Jellett, Rachel, Khan, Feroza, Lawson, Lauren P., Leslie, Jodie, Frenk, Mira Levis, Masi, Anne, Mathew, Nisha E., Muniandy, Melanie, Nothard, Michaela, Miller, Jessica L., Nunn, Lorelle, Holtmann, Gerald, Strike, Lachlan T., de Zubicaray, Greig I. ... Gratten, Jacob (2024). Erratum: autism-related dietary preferences mediate autism-gut microbiome associations. Cell, 187 (2), 495-510. doi: 10.1016/j.cell.2023.12.001

Erratum: autism-related dietary preferences mediate autism-gut microbiome associations

2024

Book Chapter

Rolle des gastrointestinalen Mikrobioms bei Erkrankungen der Darm-Hirn-Achse

Holtmann, Gerald, Shah, Ayesha and Morrison, Mark (2024). Rolle des gastrointestinalen Mikrobioms bei Erkrankungen der Darm-Hirn-Achse. Gastrointestinales Mikrobiom. (pp. 105-116) Berlin, Heidelberg: Springer Berlin Heidelberg. doi: 10.1007/978-3-662-68455-9_9

Rolle des gastrointestinalen Mikrobioms bei Erkrankungen der Darm-Hirn-Achse

2024

Journal Article

Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis

Shah, Ayesha, Jones, Michael P., Callaghan, Gavin, Fairlie, Thomas, Ma, Xiaomin, Culver, Emma L., Stuart, Katherine, De Cruz, Peter, O’Beirne, James, Tabibian, James H., Dignass, Axel, Canbay, Ali, Gores, Gregory J. and Holtmann, Gerald J. (2024). Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis. Hepatology Communications, 8 (1) e0347. doi: 10.1097/hc9.0000000000000347

Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis

2024

Conference Publication

Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis

Khoo, E., Amiss, A., Ding, J. N., Bryant, R., Mohsen, W., Connor, S., Leung, R., Croft, A., Lynch, K., Sparrow, M., De Cruz, P., An, Y. K., Holtmann, G. and Begun, J. (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. 19th Congress of ECCO, Stockholm, Sweden, 21-24 February 2024. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjad212.0984

Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis

2024

Journal Article

Preinjection With Ligation-Assisted Endoscopic Mucosal Resection for Barrett's Dysplasia and Early Esophageal Adenocarcinoma: Characteristic Histological Features of the Depth of Resection

Williams, Thomas J., Hlaing, Phyu, Maher, Adrian M., Walker, Neal, Kendall, Bradley J., Holtmann, Gerald and Hourigan, Luke F. (2024). Preinjection With Ligation-Assisted Endoscopic Mucosal Resection for Barrett's Dysplasia and Early Esophageal Adenocarcinoma: Characteristic Histological Features of the Depth of Resection. Journal of Clinical Gastroenterology, 59 (4) 2026, 321-324. doi: 10.1097/MCG.0000000000002026

Preinjection With Ligation-Assisted Endoscopic Mucosal Resection for Barrett's Dysplasia and Early Esophageal Adenocarcinoma: Characteristic Histological Features of the Depth of Resection

2023

Journal Article

TRAV26-2 T cell receptor expression is associated with mucosal lymphocyte response to wheat proteins in functional dyspepsia patients

Burns, Grace L., Potter, Michael, Mathe, Andrea, Bruce, Jessica, Minahan, Kyra, Barnes, Jessica L., Pryor, Jennifer, Nieva, Cheenie, Sherwin, Simonne, Cuskelly, Annalisa, Fairlie, Thomas, Cameron, Raquel, Bollipo, Steven, Irani, Mudar Zand, Foster, Robert, Gan, Lay T., Shah, Ayesha, Koloski, Natasha, Foster, Paul S., Horvat, Jay C., Walker, Marjorie M., Powell, Nick, Veysey, Martin, Duncanson, Kerith, Holtmann, Gerald, Talley, Nicholas J. and Keely, Simon (2023). TRAV26-2 T cell receptor expression is associated with mucosal lymphocyte response to wheat proteins in functional dyspepsia patients. Clinical and Translational Gastroenterology, 14 (12) e00638, e00638. doi: 10.14309/ctg.0000000000000638

TRAV26-2 T cell receptor expression is associated with mucosal lymphocyte response to wheat proteins in functional dyspepsia patients

2023

Conference Publication

Small intestinal bacterial overgrowth in chronic liver disease: a systematic review and meta-analysis of case-control studies

Spannenburg, L., Shah, A., Thite, P., Fairlie, T., Moniruzzaman, M., Stuart, K. A., Koloski, N. A., Morrison, M., Jones, M. P. and Holtmann, G. J. (2023). Small intestinal bacterial overgrowth in chronic liver disease: a systematic review and meta-analysis of case-control studies. 31st United European Gastroenterology Week 2023, Copenhagen, Denmark, 14-17 October 2023. Oxford, United Kingdom: John Wiley & Sons. doi: 10.1002/ueg2.1246

Small intestinal bacterial overgrowth in chronic liver disease: a systematic review and meta-analysis of case-control studies

2023

Conference Publication

Small intestinal bacterial overgrowth in chronic liver disease: A systematic review and meta-analysis of case-control studies

Spannenburg, L., Shah, A., Thite, P., Fairlie, T., Koloski, N., Moniruzzaman, M., Morrison, M., Jones, M. and Holtmann, G. (2023). Small intestinal bacterial overgrowth in chronic liver disease: A systematic review and meta-analysis of case-control studies. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Richmond, VIC Australia: John Wiley & Sons.

Small intestinal bacterial overgrowth in chronic liver disease: A systematic review and meta-analysis of case-control studies

2023

Conference Publication

Alcohol dependence and alcohol-related liver disease after bariatric surgery

Williams, T., Palmer, A., Connor, J., Holtmann, G. and Clark, P. (2023). Alcohol dependence and alcohol-related liver disease after bariatric surgery. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD, Australia, 2—5 September 2023. Richmond, VIC, Australia: John Wiley & Sons.

Alcohol dependence and alcohol-related liver disease after bariatric surgery

2023

Conference Publication

Small intestinal bacterial overgrowth in patients with intestinal failure: A systematic review and meta-analysis

Ma, X., Shah, A., Fairlie, T., Martin, N., Jones, M., Koloski, N., Morrison, M. and Holtmann, G. (2023). Small intestinal bacterial overgrowth in patients with intestinal failure: A systematic review and meta-analysis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Richmond, VIC Australia: John Wiley & Sons.

Small intestinal bacterial overgrowth in patients with intestinal failure: A systematic review and meta-analysis

2023

Journal Article

Validation of the structured assessment of gastrointestinal symptoms scale to support standardized evaluation and follow-up

Hammer, Johann, Holtmann, Gerald and Hammer, Karin (2023). Validation of the structured assessment of gastrointestinal symptoms scale to support standardized evaluation and follow-up. Journal of Pediatric Gastroenterology and Nutrition, 77 (2), 178-183. doi: 10.1097/MPG.0000000000003821

Validation of the structured assessment of gastrointestinal symptoms scale to support standardized evaluation and follow-up

2023

Journal Article

Deliberate foreign body ingestion in patients with underlying mental illness: A retrospective multicentre study

Kaazan, P., Seow, W., Tan, Z., Logan, H., Philpott, H., Huynh, D., Warren, N., McIvor, C., Holtmann, G., Clark, S.R. and Tse, E. (2023). Deliberate foreign body ingestion in patients with underlying mental illness: A retrospective multicentre study. Australasian Psychiatry, 31 (5), 619-624. doi: 10.1177/10398562231189431

Deliberate foreign body ingestion in patients with underlying mental illness: A retrospective multicentre study

2023

Journal Article

Overlap of disorders of gut–brain interaction: a systematic review and meta-analysis

Fairlie, Thomas, Shah, Ayesha, Talley, Nicholas J., Chey, William D., Koloski, Natasha, Yeh Lee, Yeong, Gwee, Kok-Ann, Jones, Michael P. and Holtmann, Gerald (2023). Overlap of disorders of gut–brain interaction: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology, 8 (7), 646-659. doi: 10.1016/s2468-1253(23)00102-4

Overlap of disorders of gut–brain interaction: a systematic review and meta-analysis

2023

Journal Article

Letter to the editor: insurance should cover vancomycin for primary sclerosing cholangitis

Ali, Ahmad H., Buness, Cynthia W., Fischer, Ryan, Holtmann, Gerald J., Shah, Ayesha, Lewindon, Peter, Shah, Shamita, Ragnekar, Amol S., Taylor, Amy E., Goel, Aparna, Cox, Kenneth L., Alrabadi, Leina, Wadsworth, Steve, Kulkarni, Sakil S. and Lindor, Keith D. (2023). Letter to the editor: insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology, 77 (6), E174-E175. doi: 10.1097/hep.0000000000000304

Letter to the editor: insurance should cover vancomycin for primary sclerosing cholangitis

Funding

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant
  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Supervision

Availability

Professor Gerald Holtmann is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Equitability and Accessibility of Faecal Occult Blood Test Based Colorectal Cancer Screening for Disadvantaged Communities.

    Principal Advisor

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

  • Doctor Philosophy

    Exercise training on people with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled trial.

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Dr Paul Clark

Completed supervision

Media

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au